U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492953) titled 'Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases' on March 11.

Brief Summary: The goal of this clinical trial is to learn whether enhanced external counterpulsation (EECP) therapy can improve cardiopulmonary function and symptoms in adults with long COVID. It will also evaluate the safety and feasibility of two different EECP treatment schedules.

The main questions it aims to answer are:

* Does EECP therapy improve functional exercise capacity and cardiopulmonary performance in patients with long COVID?

* Do different EECP treatment schedules (standard vs. accelerated se...